AbbVie News Center - News
6 days ago · AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2024 financial results on Friday, January 31, 2025, before the market opens. AbbVie will host a live webcast …
AbbVie to Acquire Landos Biopharma, Further Strengthening its
Mar 25, 2024 · NORTH CHICAGO, Ill. and NEW YORK, March 25, 2024 /PRNewswire/ -- AbbVie Inc. (NYSE: ABBV) ("AbbVie") and Landos Biopharma, Inc. (NASDAQ: LABP) ("Landos") …
AbbVie to Acquire ImmunoGen, including its Flagship Cancer
Nov 30, 2023 · ImmunoGen's follow-on pipeline complements AbbVie's oncology portfolio, which has the potential to be transformative across multiple solid tumors and hematologic …
AbbVie Announces Appointment of Robert A. Michael as Chief …
NORTH CHICAGO, Ill., Feb. 20, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that its board of directors has unanimously selected Robert A. Michael, AbbVie's current …
AbbVie Completes Acquisition of ImmunoGen - Feb 12, 2024
Feb 12, 2024 · AbbVie expects its acquisition of ImmunoGen to be accretive to AbbVie's diluted EPS beginning in 2027 and significantly accretive over the long-term. Full-Year 2024 Outlook. …
AbbVie Completes Acquisition of Cerevel Therapeutics
Aug 1, 2024 · "AbbVie's acquisition of Cerevel strengthens our foundation in neuroscience and positions us to deliver sustainable long-term performance into the next decade and beyond," …
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
Feb 2, 2024 · The acquisition accelerates AbbVie's entry into the solid tumor space and enhances AbbVie's oncology pipeline through the addition of multiple promising next-generation ADCs. …
AbbVie News Center - News
Data presented at the 66th Annual Meeting and Exposition of the American Society of Hematology (ASH) NORTH CHICAGO, Ill., Dec. 9, 2024 /PRNewswire/ -- AbbVie (NYSE: …
AbbVie to Acquire Nimble Therapeutics, Further Strengthening …
Dec 13, 2024 · NORTH CHICAGO, Ill. and MADISON, Wis., Dec. 13, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Nimble Therapeutics today announced a definitive agreement …
AbbVie Provides U.S. Regulatory Update on ABBV-951 ... - AbbVie …
Jun 25, 2024 · Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, …